RxDoctor Payments Data

Eduardo Gonzalez Hernandez, MD

Hand Surgery · Coral Gables, FLNPI 1578515532

Payments from drug & device makers

What this record shows

22 manufacturers reported payments, led by Arthrex at 58.5% of the total. Reporting peaked in 2021 at $4,132 and has fallen 88.9% since, to $459 in 2025.

$6,739in general payments, 2019–2025

Across 110 payments — averaging $61.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Amgen$611
  • Shoulder Innovations, Inc.$294
  • Anika Therapeutics, Inc.$263
  • Endo Pharmaceuticals Inc.$236
  • Zyla Life Sciences, Inc.$159
  • plus $1K from 16 others
$153,132in research payments, 2019–2025

Across 3 payments — averaging $51,044 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$153K

What the payments were for

  • Food & beverage$3,11946%
  • Education$3,62054%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,739 in reported general payments places this provider in the 70th percentile of 173 hand surgery providers in Florida.

See all hand surgery providers in Florida

Medicare billing

Part B allowed, 2024
$140,535
Medicare patients
223
Services billed
1,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen227$1,273
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$445
Diclofenac Sodium19$316
Gabapentin78$315
Mupirocin22$170
Cephalexin18$156
Celecoxib11$151
Tramadol Hcl58$150
Meloxicam39$83
Acetaminophen-CodeineAcetaminophen With Codeine11$46

Paid to pharmacies, not to this prescriber.

Other hand surgery in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →